Severe posttransfusion hyperhemolysis in a sickle cell patient produced profound anemia and lactic acidosis; terminal complement blockade with eculizumab stabilized hemolysis and enabled recovery.
In March 2026, the Central Electricity Authority released the National Generation Adequacy Plan (NGAP) for 2026-27 to 2035-36. It is one of the most comprehensive power planning exercises, combining ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsDouglas Love - CEO, President ...
CNW/ - Fortune Bay Corp. (TSXV: FOR) (FWB: 5QN) (OTCQB: FTBYF) ("Fortune Bay" or the "Company") is pleased to provide a ...
Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
Aerospace and defense activity within the S&P 500 Index includes uncrewed aircraft developments and hybrid propulsion ...
Osteoarthritis is a degenerative joint disease, in which tissues in the joint break down over time. The condition can affect ...
An estimated 595 million people globally are living with osteoarthritis. This makes it one of the leading causes of pain and ...
ELFI, a division of SouthEast Bank, today announced the launch of EdMed, a new private student loan program designed specifically for medical and healthcare ...
In an era where mental overload, digital fatigue, and age-related cognitive decline are becoming increasingly common concerns ...
This article is authored by Amol Phadke, Neelima Jain and Nikit Abhyankar.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results